Cite
HARVARD Citation
Holleran, G. et al. (n.d.). Long‐acting somatostatin analogues provide significant beneficial effect in patients with refractory small bowel angiodysplasia: Results from a proof of concept open label mono‐centre trial. United European Gastroenterology journal. 4 (1), pp. 70-76. [Online].